跳至主要内容
临床试验/IRCT20231116060076N1
IRCT20231116060076N1招募中4 期

Investigating the therapeutic effect of curcumin-peperin supplementation on metabolic syndrome, and liver fibrosis and steatosis indicators in bariatric surgery candidates: a randomized controlled trial.

Mashhad University of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with morbid obesity and candidates for bariatric surgery in the age range of 18 to 65 years
  • Diagnosis of metabolic syndrome by a specialist doctor based on biochemical and clinical analyses
  • Willingness to cooperate in the project
  • No allergies

排除标准

  • Regular consumption of multivitamin-mineral supplements, antioxidants, and omega-3 supplements in amounts exceeding the daily requirement, probiotic supplements, and consumption of herbal extracts such as silymarin during the past 3 months.
  • Diagnosed pathological conditions affecting the liver such as types of viral hepatitis and liver transplantation
  • History of gastrointestinal diseases, organ failure, thyroid disorders, kidney diseases, autoimmune diseases, severe mental diseases and types of malignancy.

研究者

相似试验

Investigating the therapeutic effect of... | 临床试验